Loading...

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

PURPOSE: To assess short-term functional and anatomical outcomes of refractory diabetic macular edema (DME) following a switch from ranibizumab or dexamethasone to aflibercept. METHODS: We included retrospectively eyes with persistent DME after at least 3 ranibizumab and/or one dexamethasone implant...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Ophthalmol
Main Authors: Herbaut, Antoine, Fajnkuchen, Franck, Qu-Knafo, Lise, Nghiem-Buffet, Sylvia, Bodaghi, Bahram, Giocanti-Auregan, Audrey
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576400/
https://ncbi.nlm.nih.gov/pubmed/28900543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8035013
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!